glp-1 agonist dpp 4 inhibitor Role of Dipeptidyl Peptidase Inhibitors in Antidiabetic Treatment GLP-1-RA and DPP-4 inhibitors in
Description
Statements Author contributions FK: Writing original draft, Visualization
But the timeline is moving later than originally hoped
Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors
This research topic will feature reviews on the structural biology, pharmacology and clinical development of GLP-1 (and related peptides) receptor agonists and multi-agonists also targeting other receptors, and of DPP-4 inhibitors
Metabolic health stayed stable
